홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

HCID 178483604, 화합물 → CID 64738

HRID 1953928
인쇄

반응식

HRID 1953928 반응식
[C:1]([O-:10])(=[O:9])[C:2]1[C:3](=[CH:5][CH:6]=[CH:7][CH:8]=1)[OH:4].[C:11]([O-:20])(=[O:19])[C:12]1[C:13](=[CH:15][CH:16]=[CH:17][CH:18]=1)[OH:14].[C:21]([O-:30])(=[O:29])[C:22]1[C:23](=[CH:25][CH:26]=[CH:27][CH:28]=1)[OH:24].[Mg+2:31].[OH:32][CH2:33][CH2:34][N+:35]([CH3:38])([CH3:37])[CH3:36]>O>[C:1]([O-:10])(=[O:9])[C:2]1[C:3](=[CH:5][CH:6]=[CH:7][CH:8]=1)[OH:4].[C:11]([O-:20])(=[O:19])[C:12]1[C:13](=[CH:15][CH:16]=[CH:17][CH:18]=1)[OH:14].[C:21]([O-:30])(=[O:29])[C:22]1[C:23](=[CH:25][CH:26]=[CH:27][CH:28]=1)[OH:24].[Mg+2:31].[OH:32][CH2:33][CH2:34][N+:35]([CH3:38])([CH3:37])[CH3:36].[C:1]([O:10][CH2:17][CH2:18][N+:35]([CH3:37])([CH3:36])[CH3:34])(=[O:9])[C:2]1[C:3](=[CH:5][CH:6]=[CH:7][CH:8]=1)[OH:4].[C:1]([O-:10])(=[O:9])[C:2]1[C:3](=[CH:5][CH:6]=[CH:7][CH:8]=1)[OH:4].[Mg+2:31].[C:1]([O-:10])(=[O:9])[C:2]1[C:3](=[CH:5][CH:6]=[CH:7][CH:8]=1)[OH:4].[C:1]([O-:10])(=[O:9])[C:2]1[C:3](=[CH:5][CH:6]=[CH:7][CH:8]=1)[OH:4]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 1

HCID 178483604HCID 178483604, 화합물2회

생성물 4

HCID 64738CID 64738HCID 130354332-(2-Hydroxybenzoyl)oxyethyl-trimethylazaniumHCID 178483604HCID 178483604, 화합물HCID 178524311CID 5148

시약·촉매·용매 1

HCID 962
Water
용매

실험 절차

A 10% solution of anionic salicylate was prepared by dissolving 10 g of choline magnesium trisalicylate (Trilisate™, Purdue Frederick, Norwalk, Conn.) in 87 g of distilled water. The mixture was stirred until the choline magnesium trisalicylate was fully dissolved. Each gram of choline magnesium trisalicylate yielded 587 mg of choline salicylate, 725 mg of magnesium salicylate being equivalent to 1 gram of salicylate content. Final composition:

후처리

  1. dissolutionwas fully dissolved

출처 및 근거

ORD 기록
ord-7225513ac9304a5285794a41bdd68eda
출처 데이터셋
uspto-grants-2000_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06120756

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트